Dr Reddy''s Launches Minoxidil For Treatment Of Female Pattern Hair Loss In India

The launch follows the first-ever approval of the additional indication by the Central Drugs Standard Control Organisation (COSCO) in India for the use of the product for the treatment of female pattern hair loss (FPHL)

B Medical Systems Joins Hands With Dr Reddy's For Pan-India Rollout Of Sputnik V Vaccines

Sputnik V, an adenovirus viral vector vaccine, needs specialised storage and is required to be kept at a temperature of -18°C or below, necessitating the need for a more stringent vaccine cold chain

Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

Shares of Dr Reddy's were trading 0.14 per cent lower at Rs 5,272.05 apiece on the BSE.

Aster DM Healthcarae Partners With Dr Reddy's To Administer Sputnik V Vaccine In Select Locations

The Kochi-based healthcare provider would initially inoculate beneficiaries in (Kochi) Kerala and Kolhapur (Maharashtra) as part of the initiative.

Rockwell Industries Ties Up With DRL For Freezers To Store Sputnik V Vaccine

Dr Reddy's announced a limited pilot soft launch of the Sputnik V vaccine in India, ahead of the commercial launch later in June.

Shilpa Medicare Arm Inks Pact With Dr Reddy's To Manufacture Sputnik V Vaccine

SBPL will be responsible for manufacture of the vaccine, while Dr Reddy's is responsible for distribution/marketing of the vaccine in its marketing territories.

Dr Reddy's Receives DCGI Approval For COVID-19 Vaccine Sputnik For Restricted Emergency Use

Dr Reddy's had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and distribute the vaccine in India.

SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V COVID vaccine

SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V COVID vaccine

DCGI directs Dr Reddy's lab to furnish fresh protocol to seek approval for Russian covid vaccine clinical trial in India

DCGI directs Dr Reddy's lab to furnish fresh protocol to seek approval for Russian covid vaccine clinical trial in India

Dr Reddy's December Quarter Net Profit Falls 16 Per Cent

Sales in North America, Dr Reddy's largest market, fell 15 percent, while those in India were up 2.4 percent, the company said in a statement

Sensex Edges Up As GST Bill Makes Headway

Dr Reddy's tanks 10 per cent after the company's consolidated net profit declined by 80 per cent for the June quarter

Dr Reddy's To Buy Eight Products In US For $350 Million

The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said

Dr Reddy's Blames Venezuelan Crisis For 86 Per Cent Profit Drop

Dr Reddy's said it took a hit of $65 million in the January-March quarter because it could not get approval from the Venezuelan government to recover any more money beyond the $4 million it has already received

Dr Reddy's Andhra, Telangana Plants Get FDA Warning

By CH Unnikrishnan Dr Reddy's Laboratories Ltd, India's second largest drug maker by revenue, said it received a warning letter from the US drug regulator over manufacturing facilities making pharmaceutical ingredients and oncology products in Andhra Pradesh and Telangana.

Indian Firms Left Behind As Biosimilars Shake Up Drug Industry